ADIM
INSP icon

Alpha DNA Investment Management’s Inspire Medical Systems INSP Stock Holding History

Alpha DNA Investment Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,275
Closed -$1M – 192
2023
Q1 		$1M Buy
+4,275
New +$1.08M 0.3% 119
2021
Q2 		– Sell
-6
Closed -$1K – 354
2021
Q1 		$1K Sell
6
-10
-63% -$2.13K ﹤0.01% 625
2020
Q4 		$3K Buy
+16
New +$2.62K ﹤0.01% 417

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Alpha DNA Investment Management's INSP Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 4,275 shares — an estimated $1M sold.

Alpha DNA Investment Management first reported a position in INSP in Q4 2020 and held it in 3 quarters. The position peaked at $1M in Q1 2023. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4,275 Inspire Medical Systems shares in Q2 2023, an estimated $1M.
  • Alpha DNA Investment Management first reported a position in Inspire Medical Systems in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Inspire Medical Systems position peaked at $1M in Q1 2023.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.